Embodiments of the present disclosure relate generally to electronics and medical diagnostic technology and, more specifically, to techniques for controlling medical device tools.
In minimally invasive medical procedures, a healthcare provider typically inserts a medical device into the body of a patient and positions the instrument head of the medical device at a target location, such as the location of a tumor. The instrument head usually includes some form of tool, such as and without limitation, a therapeutic drug delivery tool that delivers a therapeutic drug to the target location, an energy delivery tool that delivers energy (e.g., heat or electricity) to the target location, and/or a tissue sample extraction tool that can be used to extract tissue samples from the target location for further evaluation.
One problem that exists with many conventional medical devices is that operating a medical device tool at a location within the body of a patient that is different than the desired target location can damage otherwise healthy patient tissue and/or result in the target location not being properly treated. Therefore, conventional medical devices oftentimes include various mechanisms for determining the location of an associated medical device tool within the body of a patient. Some example mechanisms include, without limitation, transmitters that transmit signals that can be used for triangulation and ultrasound-visible materials that are visible in ultrasound imaging.
One drawback of the above mechanisms used for determining the location of a medical device tool with the body of a patient is that these mechanisms are oftentimes inaccurate and, accordingly, are insufficient for confirming that a given tool is positioned correctly at a given target location. More specifically, triangulating and ultrasound imaging typically require calibrating the relevant positioning system with respect to both the medical device tool and a mapping of the body of a patient generated, for example, using a medical scan. Errors introduced in the calibration process can produce errors in determining whether the medical device tool is positioned correctly at the target location. Also, any physiological changes within the patient, such as the size, shape, or location of a tumor, between the time when the medical scan is performed and the time when the medical procedure begins can change the target location. Thus, positioning a medical device tool based on a medical scan can result in applying the medical device tool to healthy tissue instead of applying the medical device tool at the target location.
As the foregoing illustrates, what is needed in the art are more effective techniques for controlling medical device tools.
Embodiments are disclosed for medical devices. In various embodiments, a medical device includes an instrument head that includes one or more electrode pairs and a medical device tool coupled to a conduit, an impedance bridge, and a processor coupled to the impedance bridge and the conduit.
Embodiments are disclosed for controlling a medical device. In various embodiments, a method includes recording, at one or more frequencies, one or more impedance measurements associated with one or more electrode pairs included in an instrument head of the medical device; determining, based on the one or more impedance measurements, a tissue type of a portion of tissue contacting the one or more electrode pairs; and performing one or more operations to control a medical device tool included in the instrument head based on the tissue type.
At least one technical advantage of the disclosed medical device relative to the prior art is that the disclosed medical device confirms that a medical device tool is positioned at a given target location before activating the medical device tool. For example, the disclosed medical device is able to determine that the tissue type of a portion of tissue contacting the electrodes in the instrument head of the medical device matches the expected tissue type at the target location prior to activating the medical device too. In this manner, the disclosed medical device is able to apply different medical device tools to tissue at various target locations more accurately than conventional medical devices. Consequently, the disclosed medical device can be used to perform various procedures, such as and without limitation, delivering therapeutic drugs or energy or extracting tissue samples, at specific target locations more accurately and reliably relative to what can be achieved with conventional medical devices. These technical advantages provide one or more technological advancements over prior art approaches.
In the following description, numerous specific details are set forth to provide a more thorough understanding of the various embodiments. However, in the range of embodiments of the concepts includes some embodiments omitting one or more of these specific details.
As shown in
As shown in
As shown in
As shown in
While not shown, in various embodiments, the electrode pairs 202 can extend and retract in a corresponding manner as the medical device tool 204 in the first configuration shown in
As technical advantages of these various embodiments, in various embodiments and without limitation, causing the medical device tool 204 to be in a retracted position until confirming that the medical device 100 is positioned at the target location 102, and then to extend, can prevent the medical device tool 204 from contacting other tissue of the patient. Similarly, causing the electrode pairs 202 to be in an extended position until confirming that the medical device 100 is positioned at the target location 102, and then to retract, can prevent the medical device tool 204 from contacting other tissue of the patient. Alternatively or additionally, in various embodiments and without limitation, causing the electrode pairs 202 to retract, and/or causing the medical device tool 204 to extend, can prevent the medical device tool 204 from altering the impedance measurements of the portion of tissue at the target location 102 by the electrode pairs 202. Alternatively or additionally, in various embodiments and without limitation, causing the electrode pairs 202 to retract, and/or causing the medical device tool 204 to extend, can prevent the medical device tool 204 from contacting the electrode pairs 202 during operations (e.g., while the medical device tool 204 delivers a therapeutic drug, delivers energy, extracts a tissue sample, or the like). Further, in various embodiments in which electrodes extend laterally outward with respect to the axis of the medical device tool 204, extending the electrode pairs 202 can cause the electrodes to contact a larger portion of tissue (e.g., impedance measurements of a large tumor), while retracting the electrode pairs 202 can cause the electrodes to contact a smaller portion of tissue (e.g., impedance measurements of a small tumor).
While the wires 104 conduct current at various frequencies, the processor 606 records one or more impedance measurements 608 of the circuit including the electrode pair 202. The processor 606 determines a tissue type 610 of a portion of tissue contacting the electrode pair 202 based on the impedance measurements 608. In various embodiments, the processor 606 determines the tissue type 610 by comparing the impedance measurements 608 with one or more characteristic impedance measurements associated with one or more tissue types. For example and without limitation, based on the comparing, the processor 606 can determine which tissue type is associated with characteristic impedance measurements that are closest to the impedance measurements of the portion of tissue contacting the electrode pair 202. In various embodiments, the processor 606 can determine a Cole relaxation frequency of the portion of tissue based on the impedance measurements 608, and can compare the Cole relaxation frequency to one or more characteristic Cole relaxation frequencies of one or more tissue types. The Cole relaxation frequency corresponds to a frequency associated with a greatest impedance measurement 608 included in the one or more impedance measurements 608. In various embodiments, the Cole relaxation frequency is a frequency of a maximum normalized impedance measurement of the portion of tissue contacting the electrode pair 202. For example and without limitation, based on a Cole relaxation frequency below a threshold frequency (e.g., 105 Hz), the processor 606 can determine that the portion of tissue contacting the electrode pair 202 is a non-tumor tissue type. Similarly, for example and without limitation, based on a Cole relaxation frequency above the threshold frequency, the processor 606 can determine that the portion of tissue contacting the electrode pair 202 is a tumor tissue type.
In various embodiments, the processor 606 performs one or more operations 612 to control the medical device tool 204 based on the determined tissue type 610. For example and without limitation, in various embodiments in which the medical device tool 204 is a therapeutic drug delivery tool, the processor 606 can perform operations 612 that include activating the therapeutic drug delivery tool to deliver one or more therapeutic drugs to the portion of tissue. For example and without limitation, in various embodiments in which the medical device tool 204 is an energy delivery tool, the processor 606 can perform operations 612 that include activating the energy delivery tool to deliver energy to the portion of tissue. For example and without limitation, in various embodiments in which the medical device tool 204 is a tissue sample extraction tool, the processor 606 can perform operations 612 that include activating the tissue sample extraction tool to extract a tissue sample from the portion of tissue. For example and without limitation, in various embodiments in which the medical device tool 204 can extend, the processor 606 can perform operations 612 that include causing the medical device tool 204 to extend from a retracted position to an extended position (e.g., by activating an actuator that is coupled to the medical device tool 204). For example and without limitation, in various embodiments in which the electrode pair 202 can retract, the processor 606 can perform operations 612 that include causing the electrode pair 202 to retract from an extended position to a retracted position (e.g., by activating an actuator that is coupled to the electrode pair 202).
In various embodiments, based on determining the tissue type 610, the processor 606 presents an indication of the tissue type 610 of the portion of tissue contacting the electrode pair 202. For example and without limitation, the processor 606 can indicate the tissue type 610 using a visual output (e.g., a light-emitting diode, a liquid crystal display, or the like) and/or an audio output (e.g., a speaker, a buzzer, or the like). In various embodiments, based on determining the tissue type 610, the processor 606 presents an indication that the determined tissue type 610 matches the tissue type of tissue at a target location 102. For example and without limitation, where the target location 102 is a tumor, the processor 606 can indicate that a determined tumor tissue type matches the tissue type of the tissue at the target location 102. Presenting the indication can inform a user of the medical device 100 that the instrument head is at the target location 102. Further, in various embodiments, the processor 606 performs the one or more operations 612 to control the medical device tool 204 based on presenting the indication that the determined tissue type 610 matches the tissue type of tissue at a target location 102 and receiving a signal to activate the medical device tool 204.
As shown, the external electrical components 106 include an amplifier 602, an impedance bridge 604, and a processor 606. The amplifier 602 amplifies a supplied voltage and/or a return voltage while the wires 104 conduct current at various frequencies between the impedance bridge 604 and the electrode pair 202. The impedance bridge 604 is an impedance load that the processor 606 measures to determine an impedance of a circuit including the impedance bridge 604, the amplifier 602, the wires 104, and the electrode pair 202. The processor 606 records, at various frequencies, one or more impedance measurements 608. The processor 606 determines a tissue type 610 of a portion of tissue contacting the electrode pair 202 based on the impedance measurements 608. In various embodiments and without limitation, the processor 606 determines the tissue type based on a Cole relaxation frequency of the portion of tissue contacting the electrode pair 202. In various embodiments and without limitation, the processor 606 determines the tissue type 610 of the portion of tissue as one of a tumor tissue type or a non-tumor tissue type. In various embodiments and without limitation, the processor 606 determines that the tissue type 610 matches the tissue type of tissue at the target location 102, which indicates or confirms that the instrument head 108 is positioned at the target location 102. For example and without limitation, if the target location 102 is a tumor, the processor 606 can determine whether the instrument head 108 is positioned at the target location 102 by determining that the tissue type 610 is a tumor tissue type.
As shown, the processor 606 is coupled to a conduit 302 of the medical device tool 204. Based on the determined tissue type 610, the processor 606 performs one or more operations 612 to control the medical device tool 204. In various embodiments and without limitation, the medical device tool 204 is a therapeutic drug delivery tool, and the processor 606 performs an operation 612 of causing the medical device tool 204 to deliver one or more therapeutic drugs to tissue at the target location 102. For example and without limitation, the processor 606 can cause one or more therapeutic drugs through one or more drug delivery conduits to and through the therapeutic drug delivery tool. In various embodiments and without limitation, the medical device tool 204 is an energy delivery tool, and the processor 606 performs an operation 612 of causing the conduit 302 and the medical device tool 204 to deliver energy to tissue at the target location 102. For example and without limitation, the processor 606 can current to be conducted through wires in the conduit 302 to and through the energy delivery tool. In various embodiments and without limitation, the medical device tool 204 is a tissue sample extraction tool, and the processor 606 performs an operation 612 of causing the tissue sample extraction tool to extract a tissue sample from tissue at the target location 102. For example and without limitation, the external electrical components 106 can include an actuator coupled to the tissue sample extraction tool by wires in the conduit 302, and the processor 606 can activate the actuator to cause the tissue sample extraction tool to extract the tissue sample.
In various embodiments, the medical device 100 reports the determined tissue type 610 to a user of the medical device 100. For example and without limitation, the medical device 100 can display an indicator of the determined tissue type 610 using a visual output (e.g., a liquid crystal display (LCD), a light-emitting diode (LED) display to present a visual indication of the tissue type 610, such as a light, symbol, text, graphic, or the like) and/or an audio indication of the determined tissue type 610 using an audio output (e.g., using a speaker, buzzer, or the like to present an audio cue of the tissue type 610, such as a spoken description, sound effect, or the like). In various embodiments and without limitation, the processor 606 can present an indication that the determined tissue type 610 matches the tissue type of tissue at the target location 102 (e.g., using a visual output, an audio output, or the like).
As shown, a method 800 begins at step 802, where a processor 606 records, at one or more frequencies, one or more impedance measurements 608 associated with one or more electrode pairs 202 included in an instrument head 108 of the medical device 100. In various embodiments and without limitation, the processor 606 determines a Cole relaxation frequency of a portion of tissue contacting the one or more electrode pairs 202 in the instrument head 108, e.g., as a frequency of a maximum normalized impedance measurement of the portion of tissue contacting the electrode pair 202.
At step 804, the processor 606 determines, based on the one or more impedance measurements 608, a tissue type 610 of a portion of tissue contacting the one or more electrode pairs 202. In various embodiments and without limitation, the processor 606 determines the tissue type as one of a tumor tissue type or a non-tumor tissue type. In various embodiments and without limitation, the processor 606 determines whether the tissue type of the portion of tissue matches a tissue type of tissue at a target location 102. In various embodiments, the processor 606 determines the tissue type 610 by comparing the impedance measurements 608 to one or more characteristic impedance measurements associated with one or more tissue types. In various embodiments and without limitation, the processor 606 determines whether the determined tissue type 610 matches a tissue type of tissue at a target location 102 (e.g., in order to determine whether the instrument head 108 is positioned at the target location 102).
At step 806, the processor 606 performs one or more operations 612 to control a medical device tool 204 included in the instrument head 108 based on the tissue type 610. For example and without limitation, based on the determined tissue type 610, the processor 606 can perform operations 612 that cause a therapeutic medical device tool to deliver a therapeutic drug to tissue at the target location 102; that cause an energy device tool to deliver energy to tissue at the target location 102; and/or to cause a tissue sample extraction tool to extract a tissue sample from tissue at the target location 102. In various embodiments, the processor 606 can use one or more of a visual output or an audio output to present an indication of the determined tissue type 610 of the portion of tissue, and/or an indication that the determined tissue type 610 matches the tissue type of tissue at a target location 102.
In sum, the disclosed medical device measures the impedance of a portion of tissue in contact with the electrodes included in the instrument head and residing at a target location. The medical device further determines the tissue type of the portion of tissue based on the measured impedance. Based on the tissue type, the medical device controls a medical device tool in the instrument head and ensures that the medical device tool is applied properly to the portion of tissue at the target location. The disclosed approach advantageously results in the medical device applying the medical device tool to tissue at a target location while avoiding portions of tissue residing at other locations.
At least one technical advantage of the disclosed medical device relative to the prior art is that the disclosed medical device confirms that a medical device tool is positioned at a given target location before activating the medical device tool. For example, the disclosed medical device is able to determine that the tissue type of a portion of tissue contacting the electrodes in the instrument head of the medical device matches the expected tissue type at the target location prior to activating the medical device too. In this manner, the disclosed medical device is able to apply different medical device tools to tissue at various target locations more accurately than conventional medical devices. Consequently, the disclosed medical device can be used to perform various procedures, such as and without limitation, delivering therapeutic drugs or energy or extracting tissue samples, at specific target locations more accurately and reliably relative to what can be achieved with conventional medical devices. These technical advantages provide one or more technological advancements over prior art approaches.
1. In some embodiments, a medical device comprises an instrument head that includes one or more electrode pairs, and a medical device tool coupled to a conduit; an impedance bridge; and a processor coupled to the impedance bridge and the conduit.
2. The medical device of clause 1, wherein the medical device tool comprises a therapeutic drug delivery tool, and the conduit includes one or more therapeutic drug delivery conduits.
3. The medical device of clauses 1 or 2, wherein the medical device tool comprises an energy delivery tool, and the conduit includes one or more wires coupling the energy delivery tool to an energy source.
4. The medical device of any of clauses 1-3, wherein the medical device tool comprises a tissue sample extraction tool, and the conduit includes one or more wires coupling the tissue sample extraction tool to an actuator.
5. The medical device of any of clauses 1-4, wherein the medical device tool resides in between the electrodes of at least one electrode pair.
6. The medical device of any of clauses 1-5, wherein at least one electrode of a given electrode pair extends laterally outward with respect to an axis of the medical device tool.
7. The medical device of any of clauses 1-6, wherein at least one electrode of a given electrode pair is made from a flexible material.
8. The medical device of any of clauses 1-7, further comprising one or more actuators that are coupled to a given electrode pair.
9. The medical device of any of clauses 1-8, further comprising an actuator coupled to the medical device tool that causes the medical device tool to extend from a retracted position to an extended position.
10. In some embodiments, a method for controlling a medical device comprises recording, at one or more frequencies, one or more impedance measurements associated with one or more electrode pairs included in an instrument head of the medical device; determining, based on the one or more impedance measurements, a tissue type of a portion of tissue contacting the one or more electrode pairs; and performing one or more operations to control a medical device tool included in the instrument head based on the tissue type.
11. The method of clause 10, wherein determining the tissue type comprises comparing the one or more impedance measurements to one or more characteristic impedance measurements associated with one or more tissue types.
12. The method of clauses 10 or 11, wherein determining the tissue type comprises determining a Cole relaxation frequency of the portion of tissue based on the one or more impedance measurements, and comparing the Cole relaxation frequency of the portion of tissue to one or more characteristic Cole relaxation frequencies of one or more tissue types.
13. The method of any of clauses 10-12, wherein the Cole relaxation frequency corresponds to a frequency associated with a greatest impedance measurement included in the one or more impedance measurements.
14. The method of any of clauses 10-13, wherein determining the tissue type comprises determining a tumor tissue type based on the Cole relaxation frequency of the portion of tissue being above a threshold frequency, or determining a non-tumor tissue type based on the Cole relaxation frequency of the portion of tissue being below the threshold frequency.
15. The method of any of clauses 10-14, wherein the medical device tool comprises a therapeutic drug delivery tool, and performing the one or more operations to control the medical device tool comprises activating the therapeutic drug delivery tool to deliver one or more therapeutic drugs to the portion of tissue.
16. The method of any of clauses 10-15, wherein the medical device tool comprises an energy delivery tool, and performing the one or more operations to control the medical device tool comprises activating the energy delivery tool to deliver energy to the portion of tissue.
17. The method of any of clauses 10-16, wherein the medical device tool is a tissue sample extraction tool, and performing the one or more operations comprises activating the tissue sample extraction tool to extract a tissue sample from the portion of tissue.
18. The method of any of clauses 10-17, wherein performing the one or more operations to control the medical device tool at least one of, causing the medical device tool to extend from a retracted position to an extended position, or causing the electrodes of at least one electrode pair to retract from an extended position to a retracted position.
19. The method of any of clauses 10-18, further comprising outputting at least one of a visual indication or an audio indication of the tissue type of the portion of tissue.
20. The method of any of clauses 10-19, further comprising outputting at least one of a visual indication or an audio indication that the tissue type of the portion of tissue matches the tissue type of tissue at a target location.
Any and all combinations of any of the claim elements recited in any of the claims and/or any elements described in this application, in any fashion, fall within the contemplated scope of the present invention and protection.
The descriptions of the various embodiments have been presented for purposes of illustration, but are not intended to be exhaustive or limited to the embodiments disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments.
Aspects of the present embodiments may be embodied as a system, method or computer program product. Accordingly, aspects of the present disclosure may take the form of an entirely hardware embodiment, an entirely software embodiment (including firmware, resident software, micro-code, etc.) or an embodiment combining software and hardware aspects that may all generally be referred to herein as a “module,” a “system,” or a “computer.” In addition, any hardware and/or software technique, process, function, component, engine, module, or system described in the present disclosure may be implemented as a circuit or set of circuits. Furthermore, aspects of the present disclosure may take the form of a computer program product embodied in one or more computer readable medium(s) having computer readable program code embodied thereon.
Any combination of one or more computer readable medium(s) may be utilized. The computer readable medium may be a computer readable signal medium or a computer readable storage medium. A computer readable storage medium may be, for example, but not limited to, an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system, apparatus, or device, or any suitable combination of the foregoing. More specific examples (a non-exhaustive list) of the computer readable storage medium would include the following: an electrical connection having one or more wires, a portable computer diskette, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), an optical fiber, a portable compact disc read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the foregoing. In the context of this document, a computer readable storage medium may be any tangible medium that can contain, or store a program for use by or in connection with an instruction execution system, apparatus, or device.
Aspects of the present disclosure are described above with reference to flowchart illustrations and/or block diagrams of methods, apparatus (systems) and computer program products according to embodiments of the disclosure. It will be understood that each block of the flowchart illustrations and/or block diagrams, and combinations of blocks in the flowchart illustrations and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine. The instructions, when executed via the processor of the computer or other programmable data processing apparatus, enable the implementation of the functions/acts specified in the flowchart and/or block diagram block or blocks. Such processors may be, without limitation, general purpose processors, special-purpose processors, application-specific processors, or field-programmable gate arrays.
The flowchart and block diagrams in the figures illustrate the architecture, functionality, and operation of possible implementations of systems, methods and computer program products according to various embodiments of the present disclosure. In this regard, each block in the flowchart or block diagrams may represent a module, segment, or portion of code, which comprises one or more executable instructions for implementing the specified logical function(s). It should also be noted that, in some alternative implementations, the functions noted in the block may occur out of the order noted in the figures. For example, two blocks shown in succession may, in fact, be executed substantially concurrently, or the blocks may sometimes be executed in the reverse order, depending upon the functionality involved. It will also be noted that each block of the block diagrams and/or flowchart illustration, and combinations of blocks in the block diagrams and/or flowchart illustration, can be implemented by special purpose hardware-based systems that perform the specified functions or acts, or combinations of special purpose hardware and computer instructions.
While the preceding is directed to embodiments of the present disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow.
The present application claims the benefit of U.S. Provisional Patent Application No. 63/142,242, filed Jan. 27, 2021; U.S. Provisional Patent Application No. 63/142,247, filed Jan. 27, 2021; U.S. Provisional Patent Application No. 63/142,254, filed Jan. 27, 2021; and U.S. Provisional Patent Application No. 63/142,260, filed Jan. 27, 2021. The subject matter of these related applications is hereby incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63142242 | Jan 2021 | US | |
63142247 | Jan 2021 | US | |
63142254 | Jan 2021 | US | |
63142260 | Jan 2021 | US |